Lobbying disclosures · Lobbying report
DXCM: third_quarter 2026 lobbying report
Issues related to global supply chains Issues related to the Administration's Executive Orders CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking CGM Coverage policies Issues related to breakthrough technology
Follow DXCM- Became public
- Oct 20, 2026, 11:00 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 1:39 PM EST
Why this is connected
Exact legal-name match: DEXCOM INC (https://www.sec.gov/Archives/edgar/data/1093557/).
Reported lobbying amounts
Expenses: $320,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/ac7c9696-06d6-4906-9ea2-cd19c2563159/","filing_uuid":"ac7c9696-06d6-4906-9ea2-cd19c2563159","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/ac7c9696-06d6-4906-9ea2-cd19c2563159/print/","filing_document_content_type":"text/html","income":null,"expenses":"320000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Billy Raines","dt_posted":"2026-10-20T11:00:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"6340 Sequence Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92121","registrant":{"id":401104564,"url":"https://lda.gov/api/v1/registrants/401104564/","house_registrant_id":null,"name":"DEXCOM, INC.","description":"Medical Device manufacturing","address_1":"6340 Sequence Drive","address_2":null,"address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92121","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BILLY RAINES","contact_telephone":"+1 317-565-3274","dt_updated":"2026-07-24T16:30:00.472960-04:00"},"client":{"id":202052,"url":"https://lda.gov/api/v1/clients/202052/","client_id":12,"name":"DEXCOM, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-07-03"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to global supply chains Issues related to the Administration's Executive Orders","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147356,"prefix":null,"prefix_display":null,"first_name":"BILLY","nickname":null,"middle_name":null,"last_name":"RAINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148459,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"MENZLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147356,"prefix":null,"prefix_display":null,"first_name":"BILLY","nickname":null,"middle_name":null,"last_name":"RAINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148459,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"MENZLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CGM Coverage policies Issues related to breakthrough technology","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147356,"prefix":null,"prefix_display":null,"first_name":"BILLY","nickname":null,"middle_name":null,"last_name":"RAINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148459,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"MENZLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in DXCM
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- May 10, 2026$100K–$250K
Sen. Tina Smith (D-MN)
$100K–$250K · Traded May 7, 2026 · disclosed May 10, 2026 · Spouse
- May 10, 2026$100K–$250K
Sen. Tina Smith (D-MN)
$100K–$250K · Traded Apr 29, 2026 · disclosed May 10, 2026 · Spouse
- Feb 15, 2026$1K–$15K
Sen. John Boozman (R-AR)
$1K–$15K · Traded Jan 26, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 12, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 8, 2025 · disclosed Jun 22, 2025
- Jun 9, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 15, 2025 · disclosed Jun 9, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.